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It is well documented that amyloid forming peptides and proteins interact with
membranes and that this correlates with cytotoxicity. To introduce the theme we give
a brief description of some amyloidogenic proteins and note their similarities with pore
forming toxins (PFTs) and cell penetrating peptides. Human stefin B, a member of the
family of cystatins, is an amyloidogenic protein in vitro. This review describes our studies
of the interaction of stefin B oligomers and prefibrillar aggregates with model membranes
leading to pore formation. We have studied the interaction between human stefin B and
artificial membranes of various compositions. We also have prepared distinct sizes and
morphologies of stefin B prefibrillar states and assessed their toxicity. Furthermore, we
have measured electrical currents through pores formed by stefin B prefibrillar oligomers
in a planar lipid bilayer setup. We finally discuss the possible functional and pathological
significance of such pores formed by human stefin B.
,
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INTRODUCTION
In nearly all neurodegenerative diseases, including Alzheimer’s
disease (AD), Parkinson’s disease (PD), frontotemporal demen-
tia, motor neuron disease, and transmissible spongiform
encephalopathy (TSE), the specific disease-related protein mis-
folds into an alternative conformation that tends to form β-sheet
rich oligomers and, eventually, amyloid fibrils. It is largely
believed, and has been shown in model systems, that the pre-
fibrillar aggregates and protofibrils are more neurotoxic than the
mature and long fibrils (Stefani and Dobson, 2003; Butterfield
and Lashuel, 2010). That toxicity takes place via membrane per-
turbation and even pore formation, is widely accepted (Stefani
and Dobson, 2003; Kagan and Thundimadathil, 2010). However,
the details of exactly how oligomers of amyloid forming peptides
and proteins make neurons less viable, and even lead to neuronal
death, remains a challenge to be resolved.
Typical amyloid forming peptides or proteins bind to
membranes, regardless of specific sequence differences. These
interactions involve both plasma membrane and intracellular
membranes such as mitochondrial (Squier, 2001; Pagani and
Eckert, 2011) and lysosomal membranes (Liu et al., 2010). The
proteins undergo transitions to β-sheet rich conformations before
or concomitant with interaction with membranes (Kagan and
Thundimadathil, 2010). Lipids can facilitate or induce the change
of protein conformations from unfolded into α-helix or β-sheet-
rich structures (Butterfield and Lashuel, 2010). Many of the
amyloid forming proteins perforate the membranes and form
actual pores (Kagan and Thundimadathil, 2010).
Morphologically and structurally, the amyloid pores are sim-
ilar to those formed by other pore-forming proteins (Parker and
Feil, 2005; Anderluh and Lakey, 2008). They have been detected in
around 20 amyloid forming proteins (some are listed in Table 1),
ranging from typical globular to intrinsically disordered proteins
or proteolytic fragments of amyloidogenic proteins. The pores
are in general quite large (3–10 nm in diameter) and relatively
non-selective for ion traffic (Butterfield and Lashuel, 2010; Kagan
and Thundimadathil, 2010). Well defined sizes and morpholo-
gies have been reported for some amyloid pores such as those
from α-synuclein (Lashuel et al., 2002) or Aβ peptide (Quist et al.,
2005).
In this review we describe membrane interactions and pore
formation induced by human stefin B, some of its mutants
and different oligomeric states. We also discuss what is known
about the possible physiological consequences. The pore form-
ing activities of some other amyloidogenic proteins and peptides
are considered and compared to the well-known pore forming
proteins.
PROTEIN FOLDING AND OLIGOMERIZATION ARE
MODULATED BY MEMBRANES
Proteins fold as encoded in their primary sequence (Anfinsen,
1973). However, in the cell, protein folding takes a regulated route
(Jaikaran et al., 2004). It takes place in a very crowded milieu,
often encountering hydrophobic membrane surfaces. The influ-
ence of membranes on protein folding and unfolding is manifold.
Important factors are membrane composition andmicro-domain
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Table 1 | Some cases of amyloid and pore forming proteins and peptides [compiled from Tables 1 and 2 in Kagan and Thundimadathil (2010)].
Disease Protein, pores shown in vitro References
Alzheimer’s disease (AD) Amyloid precursor protein, Aβ peptides (1–40, 1–42) Demuro et al., 2011; Kawahara et al., 2011
Familial amyloid polyneuropathy (finish) Gelsolin Kagan et al., 2012
Familial amyloid polyneuropathy Transthyretin Hirakura et al., 2001
Hereditary amyloid angiopathy Cystatin C Kagan and Thundimadathil, 2010
Dialysis associated amyloidosis β-2-microglobulin Hirakura and Kagan, 2001
Parkinson’s disease (PD) α-synuclein, NAC (α-synuclein fragment 65–95) Lashuel et al., 2002
Variant Creutzfeldt–Jakob disease Prion protein Kagan and Thundimadathil, 2010
Non-amyloid neurodegenerative disease (EPM1) Human stefin B (cystatin B) Rabzelj et al., 2008
Type II diabetes mellitus Islet amyloid polypeptide IAPP (amylin) Mirzabekov et al., 1996
structure. At membranes, proteins are at higher local concentra-
tions, the pH is lower, the dielectric constant drops from 80 in
water to about 2 in hydrophobic environments (Torres-Bugeau
et al., 2011). This all influences the conformation of proteins.
Ordered microdomains and less ordered lipid rafts both
participate in amyloid-induced neurotoxicity. The ordered
microdomains are composed of glycosphingolipids, cholesterol,
and sphingomyelin. Although difficult to probe, in living cells
plasma membranes co-exist as liquid crystalline and gel-like
domains (Mamdouh et al., 1998). Microdomains are part of
amyloid plaques of several origins (Gellermann et al., 2005), sup-
porting the suggestion that the oligomers of amyloid-forming
proteins assemble on microdomains (Zampagni et al., 2010).
It also is generally recognized that amyloid oligomers preferen-
tially bind lipids with anionic character, regardless of their charge
state (Torres-Bugeau et al., 2011).
PORE FORMING PROTEINS ARE PART OF INNATE
IMMUNITY
Pore forming proteins are able to perforate lipid membranes
(Anderluh and Lakey, 2010). Pore formationmay be part of a nor-
mal physiological mechanism or used by organisms for preying or
defence (Iacovache et al., 2008; Feil et al., 2010). Pore formation in
lipidmembranes is an ancient way of attack by various organisms.
Typical examples are the bacterial pore forming toxins (PFTs)
that are important virulence factors (Anderluh and Lakey, 2008).
They damage eukaryotic cell membranes and help in spreading
the bacteria within its host (Tweten, 2005; Bischofberger et al.,
2009).
Further, pore forming proteins of the mammalian immune
system, such as perforin or themembrane attack complex of com-
plement, are designed to remove unwanted cells from the body
(Voskoboinik et al., 2006; Rosado et al., 2008). Antimicrobial
host defence peptides (Kagan et al., 2012), such as defensins
and protegrins, are part of innate immunity. These predomi-
nantly β-sheet structure adopting peptides are toxic to bacteria,
fungi, and viruses. Jang et al. (2011), demonstrated that the
18 amino acid long protegrin-1 forms amyloid-like fibrils. The
action of protegrins, when released from the granules residing in
macrophages and neutrophils, is mediated by channel formation
(Sokolov et al., 1999; Capone et al., 2010). Temporins, peptides
of up to 14 amino-acids and initially in the conformation of
an amphipathic α-helix, have selective lipid binding properties
and discriminate host from target cells. In innate immunity, host
defence peptides target membranes of cancerous cells rather than
of healthy cells (Riedl et al., 2011), due to anionic lipid phos-
phatidyl serine exposed on the outer membrane of cancer cells.
Another source of negative charges on cells are sialic acid residues,
part of the glycosylation of proteins and lipids, and heparan and
chondroitin sulphate groups of proteoglycans.
Over the years many structural and functional studies have
provided an insight into the mechanism of pore formation
and the architecture of transmembrane pores. The pores are
composed of either transmembrane β-barrels (Heuck et al.,
2001) or clusters of α-helices (Kristan et al., 2009; Kagan and
Thundimadathil, 2010). The sizes of the final pores vary and
range from 2 up to 40 nm in diameter (Bischofberger et al., 2009).
The pores allow uncontrolled flow of ions and small molecules, or
even proteins in the case of large pores. The consequences of pore
formation differ and depend on the number of pores present in
the plasmamembrane, the mechanism ofmembrane binding, cell
type, etc.
Apart from cell plasma membranes the intracellular lysoso-
mal membrane can also be the target of pore forming proteins.
Some bacteria can hide in a latent state in endosomes until
they eventually exit the cell by autophagy (Bischofberger et al.,
2009). This again resembles the sequestration of amyloid aggre-
gates, such as, aggresomes and their removal from the cell by
autophagy (Perlmutter, 2006; Liu et al., 2010). One additional
similarity between amyloid oligomers and pore forming proteins
is a multistep mechanism of channel formation, which includes
oligomerization in the plane of the membrane (Bischofberger
et al., 2009). “Annular” oligomers of amyloid forming proteins
thus resemble the pores of pore forming proteins.
PORES BY AMYLOID FORMING PROTEINS
Transmembrane pores of amyloidogenic proteins are believed to
start to form from ring-like structures, i.e., annular oligomers
and resembling β barrels of pore-forming toxins. However, the
conformation of prefibrillar species is not always composed
of β-structure. There are cases where temporarily non-native
α-helical structure forms that, in contact with the membrane,
transforms to a β-structure arrangement, and again resembling
some of the PFTs (Kagan and Thundimadathil, 2010).
As a prototype of such pores, amyloid-β (Aβ) peptide has been
studied. Aβ in its soluble and oligomeric form causes synaptic
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damage in AD (Walsh et al., 2002) and problems with memory
(Lesne et al., 2006). Aβ (1–40) adopts a mixture of secondary
structures in solution. A lipid surface induces change in the
conformation and, after insertion, the peptide adopts an all-β
conformation (Williams and Serpell, 2011). It has been shown
that (Aβ) oligomers of different sizes, which also bind Congo
red, incorporate into lipid membranes and permeabilize them
(Williams et al., 2010; Williams and Serpell, 2011).
Arispe et al. (1993), reported that amyloid-β (Aβ) forms ion-
channels in lipid bilayer membranes. The channels, nowadays
termed pores, were rather large, non-selective for various cations,
Ca2+ permeable and could be blocked by Zn2+ (Arispe et al.,
1996; Kawahara et al., 1997).
It has been widely speculated that the pore forming ability of
amyloid peptides may cause imbalance of ions in the cell. Thus,
binding of toxic amyloid oligomers to the plasma membrane
and pore formation would increase influx of Ca2+, while pore
formation in mitochondrial or lysosomal membranes would fur-
ther contribute to reactive oxidative species (ROS) and metabolic
imbalance, finally leading to apoptosis (Bucciantini et al., 2002;
Stefani and Dobson, 2003; Stefani, 2010).
In the case of (Aβ) this hypothesis has been confirmed in real
brain slices. Kawahara et al. (2011) showed that oligomeric Aβ
incorporates directly into neural membranes and forms ion chan-
nels. The channels are cation-selective and lead to disruption of
calcium homeostasis. A study by Demuro (Demuro et al., 2011)
has confirmed that “single-channel Ca2+ imaging implicates Aβ
(1–42) amyloid pores in AD pathology.”
In due course, many other amyloid peptides and proteins,
among them human islet amylin, prion protein, and α-synuclein
(Kawahara et al., 2000; Lashuel et al., 2002), have been shown to
form pores in membranes and consequently to increase intracel-
lular Ca2+.
α-Synuclein is a protein, mutations of which have been shown
to lead to protein accumulation in Lewy bodies, with a direct
link to PD. It is known that the N-terminal part of α-synuclein
is the membrane binding region (Butterfield and Lashuel, 2010).
Molecular dynamics simulations suggest that it adopts an α 11/3
helix (Mihajlovic and Lazaridis, 2008). If this part is deleted,
α-synuclein is no longer toxic to yeast (Volles and Lansbury, 2007;
Vamvaca et al., 2009). α-Synuclein, like many amyloid form-
ing proteins, binds preferentially to anionic membranes and the
dimeric form binds more strongly to lipid membranes than the
monomer (Giannakis et al., 2008). Protofibrillar α-synuclein was
shown to permeabilize lipid membranes and exerts a “pore-like
mechanism” (Volles and Lansbury, 2002).
Human amylin is a polypeptide of 37-amino acids secreted
from pancreatic islet β-cells. It accumulates as islet amyloid in
type 2 diabetes. Human amylin (islet amyloid polypeptide—
IAPP) disrupts membrane integrity (Last et al., 2011) and readily
forms ion pores in planar lipid bilayers (Mirzabekov et al., 1996).
Initially it binds to anionic vesicles in an α-helical conforma-
tion, where the amphipathic α-helix binds in parallel to the
membrane surface. Factors of membrane microenvironment and
protein concentration transform the peptide to a β-sheet con-
formation and amyloid-like aggregates (Butterfield and Lashuel,
2010).
Not only intrinsically disordered proteins such as α-synuclein
and prion protein, or largely unstructured peptides such as
amylin or Aβ, were shown to form pores. Even globular proteins
such as β2-microglobulin (Hirakura and Kagan, 2001) or stefin
B (described in this review—as below) have similar properties,
when they undergo conversion to a β-rich conformation and form
prefibrillar oligomers.
An interesting example is BASP1, an abundant brain protein,
which is myristoylated and situated on the inner side of the presy-
naptic plasma membrane. Until now, this protein has not been
implicated in any amyloid disease. However, electrophysiological
recordings have demonstrated that BASP1 channels are similar to
amyloid protein channels. They induce single channel currents
and independent of the voltage, into negatively charged planar
lipid bilayers (Ostroumova et al., 2011).
In Table 1 some examples of the amyloid proteins, which have
been proven to make pores, are listed; a more extensive number
has been described elsewhere (Anderluh and Lakey, 2010; Kagan
and Thundimadathil, 2010). Comprehensive reviews of the ability
of amyloid proteins to form pores have been written by Kagan and
colleagues (Kagan et al., 2004, 2012; Kagan and Thundimadathil,
2010).
PORE FORMATION BY HUMAN STEFIN B
Human stefin B (cystatin B) is a cysteine protease inhibitor (Turk
et al., 2008). Its mutants cause a rare progressive myoclonus
epilepsy of type 1—EPM1 (Lalioti et al., 1997; Genton, 2010).
Stefin B is a small globular protein of 11 kDa with no disulphide
bonds. This intracellular protein resides both in the cytoplasm
and in the nucleus, where it was shown to bind to histones, how-
ever, its exact nuclear function is not yet known (Ceru et al.,
2010). It may have alternative functions, for example it was impli-
cated in innate immunity and NO production (Lefebvre et al.,
2004) or prevention of oxidative stress (Lehtinen et al., 2009).
It was found to form oligomers in vitro and in the cellular
environment (Cipollini et al., 2008). It also was proven to be amy-
loidogenic in vitro (Zerovnik et al., 2002a, 2007). Its homolog,
human stefin A, similarly forms amyloid fibrils and dimers in
vitro, however, this happens only under extreme conditions of
temperature and pH (Jenko et al., 2004). Many amyloid forming
proteins, especially in prefibrillar and oligomeric states, have been
shown to bind to membranes and to perforate them (Kawahara
et al., 2000). For these reasons, stefin B membrane interactions
and cyto-toxicity have been studied in detail.
It was shown that stefin B forms amyloid fibrils in vitro
under mild, physiologically relevant conditions (Zerovnik et al.,
2002a,b,c), unlike the more stable homologous human stefin A
(Jenko et al., 2004). The existence of different prefibrillar species
at pH 3, high salt (starting from a structured molten globule and
bearing helical structure), or at pH 5, 0.15M salt (starting from
a native-like intermediate) was shown. In both cases, after some
time, all-β sheet structure formed, concomitant with fibril forma-
tion (Zerovnik et al., 2002b). Oligomerization to globules of sizes
from 5 to 10 nm at pH 5 and from 15 to 20 nm (cross-diameter)
at pH 3 was observed for the prefibrillar states, respectively. These
oligomers contained from 6 to 32 monomers, as judged by the
approximate volume of the molecules and confirmed by size
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exclusion chromatography and dynamic light scattering (Jenko
Kokalj et al., 2007; Ceru et al., 2008). Therefore, well-defined
oligomers of stefin B may be prepared by size exclusion chro-
matography (Figure 1A) (Ceru et al., 2008), in contrast to some
other systems such as Aβ or α-synuclein.
The prefibrillar states were prepared at pH 4.8 and 3.3, as
described (Zerovnik et al., 2002b; Ceru et al., 2008). The inter-
action of the prefibrillar oligomers and aggregates of stefin B with
membranes was studied by various biophysical approaches. In
our first paper on the interaction of the prefibrillar oligomeric
forms of stefin B with membranes and correlation with toxicity
by Anderluh et al. (2005), we showed that toxicity to SH-SY5Y
neuroblastoma cells was produced by the prefibrillar aggregates
of stefin B, obtained at both pH 4.8 and 3.3, and was concen-
tration dependent. However, even the protein at pH 7.3 was
slightly toxic. This can be understood as it is actually a mixture
of oligomers (Rabzelj et al., 2005; Ceru et al., 2008). The prefib-
rillar states of stefin B showed concentration-dependent release of
FIGURE 1 | Monomers and separated oligomers of human
recombinant stefin B-E31 variant. (A) Elution volumes of a sample
composed of monomers, dimers, tetramers, and higher oligomers after
application to SEC Superdex 75 column. (B) Only higher oligomers
(triangles) were shown to insert into lipid monolayers to some degree.
(B) modified from Amyloid, Informa Health Care with permission.
the fluorescent probe calcein from unilamellar lipid vesicles com-
posed of negatively charged lipids. Liposomes composed solely
of phosphatidylcholine were not permeabilized. A homologous
protein, stefin A, did not permeabilize liposomes of any lipid
composition. Membrane interactions were further studied by
surface plasmon resonance (SPR) and lipid monolayer inser-
tion. In both cases prefibrillar aggregates showed interactions
predominantly with negatively charged lipids (Anderluh et al.,
2005).
Rabzelj et al. (2008) have shown that wild-type (wt) stefin B
and its variant with tyrosine at position 31 (stefin B-Y31), instead
of the glutamic acid in the wt, can form pores in the planar lipid
bilayers setup (Figure 2). A mutant observed in patients with
EPM1—G4R of the wt protein was also studied. This mutant
is stable and folded (Rabzelj et al., 2005) albeit it differs in one
positive charge from the wt. In the case of wt protein discrete
increases of the current were observed, indicating pore opening
(Figure 2) while, with the prefibrillar state of stefin B-Y31 vari-
ant, larger pores were observed that remained open for longer
times. The G4Rmutant exhibited very rapid and stochastic mem-
brane damaging effects. It was frequently observed that addition
of G4R led to membrane breaks after some minutes, indicating
very strong membrane interaction (Figure 2). These results were
in agreement with SPR measurements and insertion into lipid
monolayers (Rabzelj et al., 2008).
Not only the acid aggregated states of stefin B but also the
higher oligomers (higher than tetramers) of the wild type (wt)
protein isolated at pH 7 proved toxic to cells (Ceru et al., 2008).
What is of interest here is the clear distinction between oligomer
size and toxicity. In the case of stefin B wt, the monomers,
dimers, and tetramers are not toxic and toxicity starts with the
higher species (Figure 1A) such as hexamers and dodecamers. As
known from studies by TEM and AMF, such structures resem-
ble micelles and are annular in shape, which is the case for
membrane interacting oligomers of other amyloid-forming tox-
ins, such as α-synuclein (Lashuel et al., 2002). The oligomers
from 6 to 12-mers inserted better than monomers, dimers, and
tetramers (Figure 1B). The lipid monolayer insertion correlated
well with the cytotoxicity of isolated oligomers (Ceru et al.,
2008).
POSSIBLE FUNCTIONAL ROLE OF THE OLIGOMERS
AND PORES OF STEFIN B
Amyloid fibrils, from bacteria to humans, can serve a func-
tional physiological role under certain conditions (Fowler et al.,
2007). Such is the well-known example of polymeric and fib-
rillar Pmel17 which plays an important role in the biosynthesis
and storage of the pigment melanin. Intracellular Pmel17 amy-
loidogenesis is carefully orchestrated by the secretory pathway,
utilizing membrane sequestration and proteolysis to protect the
cell from potentially toxic amyloidogenic intermediates (Fowler
et al., 2006; Watt et al., 2009). Recently, prion-like amplification
of oligomers by Drosophila Orb2 was implicated in long-term
memory (Majumdar et al., 2012) as predicted earlier (Wickelgren,
2004).
In our study of membrane interaction and pore formation
by stefin B native state and its oligomers, including prefibrillar
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FIGURE 2 | Pore formation in planar lipid bilayers by some of the stefin B
variants. Pore formation measured by electrophysiological recordings is
shown for native wild-type stefin B (A) stefin B-Y31 variant (B) and
membrane destabilization by G4R (C). The break of the membrane is
denoted by an arrow. Figure modified from FEBS J., John Wiley and Sons
with permission.
aggregates (Anderluh et al., 2005; Rabzelj et al., 2008), we have
shown that the wild type protein forms cation selective pores
(Rabzelj et al., 2008), which is not necessarily deleterious for the
cell. It was suggested that pores formed by Aβmay be prosurvival
(Plant et al., 2006).
Stefin B oligomers do exist in cells (Cipollini et al., 2008).
However, at present there is no evidence, as was demonstrated
for Aβ (Kawahara et al., 2011) in AD, that pores formed by stefin
B in vitro also form in cells. Regarding their potential functional
role, this protein has some additional, cathepsin independent
functions. It forms part of the cytoskeletal complex (Di Giaimo
et al., 2002), it may be part of cellular signaling to the nucleus,
where it was found to bind histones (Ceru et al., 2010), and it
has an anti-oxidant function (Lehtinen et al., 2009). Its protec-
tive, anti-oxidant and anti-aging roles may be similar to those of
cystatin C, which was in addition shown to induces autophagy
(Tizon et al., 2010a,b) by an as yet unknownmechanism. We pro-
pose that some of these alternative functions may be due to the
protein’s oligomeric states. It has been reported that stefin B is
involved in the invertebrate innate immunity response (Lefebvre
et al., 2004), a precursor to the mammalian system (Salzet et al.,
2006). In accordance with their neuro-protective role, stefin B
is overexpressed after seizures (D’Amato et al., 2000) and cys-
tatin C in status epilepticus (Pirttila et al., 2005; Kaur et al.,
2010).
CONCLUSIONS
Amyloid forming proteins have a strong tendency to interact
with lipid membranes and to make pores (perforate the mem-
branes). The behavior of amyloid forming proteins is, in many
ways, comparable to that of bacterial toxins and innate immu-
nity membrane perforating proteins, as well as anti-bacterial
peptides.
Stefin B prefibrillar states, as well as higher oligomers, hex-
amers and higher, behave similarly to those of other amy-
loid forming proteins and peptides. What is of interest in the
case of stefin B is the observation that the wild type pro-
tein also forms smaller pores as well as the rather stable
G4R mutant observed in some patients with EPM1 (Rabzelj
S, 2006, PhD thesis, University of Ljubljana). This latter
mutant exhibits especially strong perturbation on membranes.
We believe that pore formation by the wild type stefin B
may be related to epileptogenesis, either by exerting some
protective/regulatory function on the membrane excitability,
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or by acting via the host defence system. It is known that stefin B
is involved in the innate immunity response (Lefebvre et al., 2004)
and that it is over-expressed after epileptic seizures (D’Amato
et al., 2000).
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